Insomnia Clinical Trial
Official title:
Cognitive Behavioral Therapy and Trazodone Effects on Sleep and Blood Pressure in Insomnia Phenotypes Based on Objective Sleep Duration: A Sequential Cohort/Randomized Controlled Trial
Individuals who have insomnia with short sleep duration (ISS) differ from individuals who have insomnia with normal sleep duration (INS) in terms of health risks (i.e., hypertension) and treatment response. This study will examine whether patients with ISS and INS demonstrate a differential response to two common insomnia treatments. One is behavioral, Cognitive Behavioral Therapy for Insomnia (CBT-I). The other is a widely prescribed, non-habit-forming medication, trazodone used at a low dose. The investigators' findings could lead to evidence-based treatment guidelines that help clinicians more effectively match treatments to insomnia patients and reduce associated health problems.
Status | Recruiting |
Enrollment | 600 |
Est. completion date | February 2028 |
Est. primary completion date | February 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Age 18 or older - Able to read and effectively communicate in English at the United States sites or able to read and effectively communicate in English or French at the Canadian site. - Meets criteria for chronic insomnia - Takes anti-hypertensive medication (same regimen for at least 3 months); or elevated blood pressure, defined as seated SBP =120 mmHg or DBP =80 mmHg, measured in the research clinic - Body Mass Index (BMI) 18.5-<40 kg/m2 Exclusion Criteria: - Age < 18 - Unable to read and effectively communicate in English at the United States sites or able to read and effectively communicate in English or French at the Canadian site. - Unwilling to share email address/cell phone number to accept survey links. - Life time diagnosis of psychotic or bipolar disorder - Current use of Positive Airway Pressure (PAP) therapy - Does not meet criteria for chronic insomnia - Meets criteria for narcolepsy or hypersomnia disorder - Meets criteria for circadian rhythm disorder (including night shift work) - Unstable medical conditions that would make participation unsafe or unfeasible - Falls resulting in hospitalization, significant injury or fracture within past 12 months - 2 hospitalizations or emergency room visits within past 12 months for chronic conditions - Active chemotherapy or radiation therapy for cancer - Lifetime diagnoses/treatment of chronic renal failure, hepatic insufficiency, chronic heart failure - Does not agree to refrain from other treatments for insomnia beyond what is offered in this study - BMI less than 18.5 or greater than 40 - Substance abuse or dependence in the past 12 months - Current use of prescription or over the counter medications taken for sleep greater than 2 times per week - Current use of systemic corticosteroids or opiate medications - Current pregnancy or breastfeeding; plans to get pregnant or unwillingness to use birth control for the length of the study - Current use of medications contraindicated with trazodone - Sleep apnea or periodic leg movement disorder as determined by sleep study - Blood Pressure levels defined as seated SBP greater than 180 or DBP greater than 110 mmHg - EKG corrected QT interval greater than or equal to 500 ms |
Country | Name | City | State |
---|---|---|---|
Canada | Université Laval | Quebec | |
United States | National Jewish Health | Denver | Colorado |
United States | Penn State University | Hershey | Pennsylvania |
United States | University of Pittsburgh | Pittsburgh | Pennsylvania |
Lead Sponsor | Collaborator |
---|---|
Milton S. Hershey Medical Center | National Heart, Lung, and Blood Institute (NHLBI) |
United States, Canada,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Remission of insomnia symptoms following Cognitive Behavioral Therapy for Insomnia (CBT-I) | Based on Insomnia Severity Index (ISI) published criteria; 0-28, with 0 being mild and 28 being severe | 9 weeks | |
Primary | Remission of insomnia symptoms following trazodone/placebo Randomized Controlled Trial (RCT) | Based on Insomnia Severity Index (ISI) published criteria; 0-28, with 0 being mild and 28 being severe | 9 weeks | |
Primary | Remission of insomnia symptoms 6 months following completion of CBT-I Or RCT Treatment | Based on Insomnia Severity Index (ISI) published criteria; 0-28, with 0 being mild and 28 being severe | 35 weeks | |
Secondary | Insomnia Severity Index (ISI) Score following CBT-I | 0-28, with 0 being mild and 28 being severe | 9 weeks | |
Secondary | Polysomnography (PSG) Sleep efficiency following Cognitive Behavioral Therapy for Insomnia (CBT-I) | Polysomnography (PSG) Sleep efficiency measured as a percentage of time asleep during sleep study | 9 weeks | |
Secondary | Actigraphy Sleep efficiency following Cognitive Behavioral Therapy for Insomnia (CBT-I) | Actigraphy Sleep efficiency measured as estimated sleep time at home (2 week period) | 9 weeks | |
Secondary | Evening Cortisol levels following CBT-I | Cortisol levels measured in saliva collected following CBT-I | 9 weeks | |
Secondary | Insomnia Severity Index (ISI) Score following RCT | 0-28, with 0 being mild and 28 being severe | 9 weeks | |
Secondary | PSG Total Sleep Time (TST) following RCT | PSG Total Sleep Time measured in minutes asleep during sleep study following RCT | 9 weeks | |
Secondary | Actigraphy Total Sleep Time (TST) following RCT | Actigraphy Total Sleep Time measured in minutes asleep during home study following RCT | 9 weeks | |
Secondary | Home Blood Pressure (HBP) Morning Systolic Blood Pressure (SBP) | Morning SBP Blood Pressure Readings measured at home (7 day period) | 9 weeks | |
Secondary | Home Blood Pressure (HBP) Morning Diastolic Blood Pressure (DBP) | Morning DBP Blood Pressure Readings measured at home (7 day period) | 9 weeks | |
Secondary | Evening Cortisol levels following RCT | Cortisol levels measured in saliva collected following RCT | 9 weeks | |
Secondary | Evening Cortisol levels 6 months following completion of CBT-I or RCT Treatment | Cortisol levels measured in saliva 6 months following CBT-I Or RCT Treatment | 35 weeks |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04512768 -
Treating Comorbid Insomnia in Transdiagnostic Internet-Delivered Cognitive Behaviour Therapy
|
N/A | |
Recruiting |
NCT05963542 -
Efficacy of Online Acceptance and Commitment Therapy and Sound Therapy for Patients With Tinnitus and Insomnia
|
N/A | |
Completed |
NCT06339853 -
Study of Efficacy of Digital Cognitive Behavioral Therapy With Wearable Device for Insomnia
|
N/A | |
Recruiting |
NCT04069247 -
Effectiveness of eCBT-I on Improving Mental Health in Chinese Youths With Insomnia
|
N/A | |
Completed |
NCT04493593 -
Internet-delivered CBT-I (Space for Sleep): Pilot and Feasibility
|
N/A | |
Recruiting |
NCT05956886 -
Sleep Chatbot Intervention for Emerging Black/African American Adults
|
N/A | |
Recruiting |
NCT06278077 -
Neurexan - a Clinical Trial in Short-Term Insomnia Patients
|
Phase 2 | |
Completed |
NCT04661306 -
The Better Sleep for Supporters With Insomnia Study
|
N/A | |
Recruiting |
NCT06207279 -
Preliminary Study on the Development and Reliability and Validity of Attention Rating Scale
|
||
Recruiting |
NCT06006299 -
Investigating the Use of taVNS to Treat Insomnia in Individuals With Breast Cancer (taVNS-insomnia-BC)
|
N/A | |
Completed |
NCT03683381 -
App-based Intervention for Treating Insomnia Among Patients With Epilepsy
|
N/A | |
Completed |
NCT04564807 -
Testing an Online Insomnia Intervention
|
N/A | |
Completed |
NCT03673397 -
The Acute Effect of Aerobic Exercise on Sleep in Patients With Depression
|
N/A | |
Completed |
NCT04035200 -
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
|
Phase 2 | |
Active, not recruiting |
NCT05027438 -
Reducing Use of Sleep Medications Assisted by a Digital Insomnia Intervention
|
N/A | |
Recruiting |
NCT06053840 -
An Open-label Trial to Evaluate the Safety and Efficacy of Chloral Hydrate in Patients With Severe Insomnia
|
Phase 4 | |
Not yet recruiting |
NCT06348082 -
Project Women's Insomnia Sleep Health Equity Study (WISHES)
|
N/A | |
Not yet recruiting |
NCT06363799 -
Osteopathic Protocol for Insomnia in College Students
|
N/A | |
Not yet recruiting |
NCT06025968 -
Digital Cognitive-behavioral Therapy for Insomnia for Patients With Multiple Sclerosis
|
N/A | |
Not yet recruiting |
NCT05991492 -
Improving Sleep With a Digital Cognitive Behavioral Therapy for Insomnia Application
|
N/A |